Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alexion, X-Chem in Drug Discovery Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Alexion, X-Chem in Drug Discovery Alliance

X-Chem to identify drug candidates against Alexion targets

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

X-Chem, Inc. has entered a drug discovery collaboration with Alexion, under which X-Chem will deploy its drug discovery platform to identify novel drug candidates against targets chosen by Alexion. The platform is based on an expansive, high-diversity library of more than 100 billion molecules.
 
Alexion will have exclusive worldwide rights to develop and commercialize novel compounds arising from the collaboration. X-Chem will receive an upfront payment and additional payments upon specified research, development, and regulatory milestones, as well as royalties on the sales.
 
“This agreement with X-Chem is an important element of Alexion’s strategy for addressing targets and developing first-in-class therapeutics for patients with life-threatening and ultra-rare disorders,” said Martin Mackay, Ph.D., executive vice president and head of Global R&D at Alexion. “We are very pleased to collaborate with X-Chem and gain access to their innovative platform.”
 
“X-Chem is excited to collaborate with Alexion, a leader in the treatment of patients with severe, rare diseases,” said Richard W. Wagner, Ph.D., chief executive officer of X-Chem. “This collaboration will enable Alexion to leverage the power of X-Chem’s discovery engine for pursuing challenging targets of clinical importance.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics